- Home
- KGC vs ASND Comparison
KGC vs ASND Comparison
Compare KGC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KGC
- ASND
- Stock Information
- Founded
- KGC 1993
- ASND 2006
- Country
- KGC Canada
- ASND Denmark
- Employees
- KGC N/A
- ASND N/A
- Industry
- KGC Precious Metals
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- KGC Basic Materials
- ASND Health Care
- Exchange
- KGC Nasdaq
- ASND Nasdaq
- Market Cap
- KGC 15.8B
- ASND 9.1B
- IPO Year
- KGC N/A
- ASND 2015
- Fundamental
- Price
- KGC $14.77
- ASND $159.39
- Analyst Decision
- KGC Buy
- ASND Strong Buy
- Analyst Count
- KGC 4
- ASND 16
- Target Price
- KGC $13.50
- ASND $213.88
- AVG Volume (30 Days)
- KGC 21.6M
- ASND 587.4K
- Earning Date
- KGC 05-06-2025
- ASND 05-01-2025
- Dividend Yield
- KGC 0.81%
- ASND N/A
- EPS Growth
- KGC 177.99
- ASND N/A
- EPS
- KGC 0.98
- ASND N/A
- Revenue
- KGC $5,564,800,000.00
- ASND $398,509,511.00
- Revenue This Year
- KGC $15.39
- ASND $62.61
- Revenue Next Year
- KGC $0.39
- ASND $72.16
- P/E Ratio
- KGC $15.06
- ASND N/A
- Revenue Growth
- KGC 26.71
- ASND 12.06
- 52 Week Low
- KGC $7.17
- ASND $111.09
- 52 Week High
- KGC $15.96
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- KGC 57.12
- ASND 49.26
- Support Level
- KGC $13.87
- ASND $164.24
- Resistance Level
- KGC $15.96
- ASND $183.00
- Average True Range (ATR)
- KGC 0.60
- ASND 7.80
- MACD
- KGC -0.04
- ASND -0.49
- Stochastic Oscillator
- KGC 46.65
- ASND 20.85
About KGC Kinross Gold Corporation
Kinross Gold is a Canada-based gold producer, producing roughly 2.2 million gold equivalent ounces in 2023. The company had about a decade of gold reserves at the end of 2023. It operates mines in the Americas and West Africa after selling its low-cost Russian operations in 2022 in response to the invasion of Ukraine. The company has historically used acquisitions to fuel expansion into new regions and production growth. In 2022, Kinross purchased the Great Bear project in Canada, which, if developed, could produce an average of more than 500,000 ounces of gold per year for at least a decade.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.